{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:33:14Z","timestamp":1768869194592,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1038\/s41390-021-01569-5","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T09:02:23Z","timestamp":1621242143000},"page":"1536-1541","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Genetic polymorphism of interleukin-1 receptor antagonist in Type 1 diabetic children"],"prefix":"10.1038","volume":"91","author":[{"given":"Neveen T.","family":"Abed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail A.","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzan A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman M.","family":"El-Shanawany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,17]]},"reference":[{"key":"1569_CR1","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.2337\/dc09-S062","volume":"32","author":"American Diabetes Association.","year":"2009","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 32, S62\u2013S67 (2009).","journal-title":"Diabetes Care"},{"key":"1569_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.molmet.2018.06.003","volume":"14","author":"SJ Burke","year":"2018","unstructured":"Burke, S. J. et al. Pancreatic deletion of interleukin 1 receptor disrupt whole body glucose hemostasis and promotes islet beta cell differentiation. Mol. Metab. 14, 95\u2013107 (2018).","journal-title":"Mol. Metab."},{"key":"1569_CR3","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","volume":"117","author":"CA Dinarello","year":"2011","unstructured":"Dinarello, C. A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117, 3720\u20133732 (2011).","journal-title":"Blood"},{"key":"1569_CR4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1359-6101(02)00020-5","volume":"13","author":"WP Arend","year":"2002","unstructured":"Arend, W. P. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 13, 323\u2013340 (2002).","journal-title":"Cytokine Growth Factor Rev."},{"key":"1569_CR5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1006\/geno.1994.1076","volume":"19","author":"MJ Nicklin","year":"1994","unstructured":"Nicklin, M. J., Weith, A. & Duff, G. W. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics 19, 382\u2013384 (1994).","journal-title":"Genomics"},{"key":"1569_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1600-051X.1997.tb01187.x","volume":"24","author":"KS Kornman","year":"1997","unstructured":"Kornman, K. S. et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J. Clin. Periodontol. 24, 72\u201377 (1997).","journal-title":"J. Clin. Periodontol."},{"key":"1569_CR7","doi-asserted-by":"crossref","unstructured":"BorilovaLinhartova, P. et al. Interleukin-1 gene variability and plasma levels in Czech patients with chronic periodontitis and diabetes mellitus. Int. J. Dent. 2019, 6802349 (2019).","DOI":"10.1155\/2019\/6802349"},{"key":"1569_CR8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/sj.gene.6364393","volume":"8","author":"S Rafiq","year":"2007","unstructured":"Rafiq, S. et al. Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels. Genes Immun. 8, 344\u2013351 (2007).","journal-title":"Genes Immun."},{"key":"1569_CR9","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.2337\/dc10-S062","volume":"33","author":"American Diabetes Association.","year":"2010","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 33, S62\u2013S69 (2010).","journal-title":"Diabetes Care"},{"key":"1569_CR10","first-page":"1","volume":"8","author":"RJ Kuczmarski","year":"2000","unstructured":"Kuczmarski, R. J. et al. CDC growth charts: United States. Adv. Data 8, 1\u201327 (2000).","journal-title":"Adv. Data"},{"key":"1569_CR11","doi-asserted-by":"publisher","first-page":"478","DOI":"10.2144\/97223st01","volume":"22","author":"WW Wilfinger","year":"1997","unstructured":"Wilfinger, W. W., Mackey, K. & Chomczynski, P. Effect of pH and ionic strength on the spectrophotometric assessment of nucleic acid purity. Biotechniques 22, 478\u2013481 (1997).","journal-title":"Biotechniques"},{"key":"1569_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4103\/1817-1737.94523","volume":"7","author":"MJ Hsu","year":"2012","unstructured":"Hsu, M. J., Lu, Y. C., Hsu, Y. C., Liu, W. S. & Wu, W. T. Interleukin-1 receptor antagonist gene polymorphism in patients with multidrug-resistant Acinetobacter baumannii-associated pneumonia. Ann. Thorac. Med. 7, 74\u201377 (2012).","journal-title":"Ann. Thorac. Med."},{"key":"1569_CR13","doi-asserted-by":"crossref","unstructured":"Deshpande, S. S. In Enzyme Immunoassays from Concept to Product Development 1st edn. Ch. 2 (International Thomson Publishing, 1996).","DOI":"10.1007\/978-1-4613-1169-0"},{"key":"1569_CR14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/BF02346180","volume":"97","author":"FE Clay","year":"1996","unstructured":"Clay, F. E. et al. Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment. Hum. Genet. 97, 723\u2013726 (1996).","journal-title":"Hum. Genet."},{"key":"1569_CR15","first-page":"3701","volume":"19","author":"RA Ali","year":"2015","unstructured":"Ali, R. A., Sabe, L. M. & Al-harbi, A. M. A novel association between IL1-Ra (receptor antagonist) gene polymorphism and T1DM in Al-Madina Al-Mounawra. Eur. Rev. Med. Pharmacol. Sci. 19, 3701\u20133708 (2015).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"1569_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/08916930802292510","volume":"42","author":"A Settin","year":"2009","unstructured":"Settin, A., Ismail, A., El-Magd, M. A., El-Baz, R. & Kazamel, A. Gene polymorphisms of TNF-alpha-308 (G\/A), IL-10(-1082) (G\/A), IL-6(-174) (G\/C) and IL-1Ra (VNTR) in Egyptian cases with type 1 diabetes mellitus. Autoimmunity 42, 50\u201355 (2009).","journal-title":"Autoimmunity"},{"key":"1569_CR17","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.2337\/diabetes.51.12.3582","volume":"51","author":"R Marculescu","year":"2002","unstructured":"Marculescu, R. et al. Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes. Diabetes 51, 3582\u20133585 (2002).","journal-title":"Diabetes"},{"key":"1569_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1086\/338261","volume":"34","author":"S Witkin","year":"2002","unstructured":"Witkin, S., Gerber, S. & Ledger, W. J. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin. Infect. Dis. 34, 204\u2013209 (2002).","journal-title":"Clin. Infect. Dis."},{"key":"1569_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/BF02185776","volume":"97","author":"AI Blakemore","year":"1996","unstructured":"Blakemore, A. I. et al. Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum. Genet. 97, 369\u2013374 (1996).","journal-title":"Hum. Genet."},{"key":"1569_CR20","first-page":"806","volume":"7","author":"AM El-Said","year":"2011","unstructured":"El-Said, A. M., Abdel-Aziz, A. F., Settin, A. A. & El-Sharabasy, M. M. Incidence of genetic polymorphism of IL1-Ra and IL-4 in Egyptian and other populations. J. Am. Sci. 7, 806\u2013814 (2011).","journal-title":"J. Am. Sci."},{"key":"1569_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3390\/cancers12020283","volume":"12","author":"LN Al-Eitan","year":"2020","unstructured":"Al-Eitan, L. N., Al-Ahmad, B. H. & Almomani, F. A. The association of IL-1 and HRAS gene polymorphisms with breast cancer susceptibility in a Jordanian population of Arab descent: a genotype-phenotype study. Cancers 12, 283 (2020).","journal-title":"Cancers"},{"key":"1569_CR22","first-page":"5759","volume":"18","author":"S Cauci","year":"2019","unstructured":"Cauci, S. et al. Interleukin 1 receptor antagonist gene variable number of tandem repeats polymorphism and cutaneous melanoma. Oncol. Lett. 18, 5759\u20135768 (2019).","journal-title":"Oncol. Lett."},{"key":"1569_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.aott.2019.07.004","volume":"53","author":"B Xu","year":"2019","unstructured":"Xu, B. et al. Meta-analysis of the association of IL1-RN variable number of tandem repeats polymorphism with osteoarthritis risk. Acta Orthop. Traumatol. Turc. 53, 497\u2013501 (2019).","journal-title":"Acta Orthop. Traumatol. Turc."},{"key":"1569_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4103\/ijdvl.IJDVL_1_17","volume":"84","author":"M Singh","year":"2018","unstructured":"Singh, M., Mansuri, M. S., Jadeja, S. D., Marfatia, Y. S. & Begum, R. Association of interleukin 1 receptor antagonist intron 2 variable number of tandem repeats polymorphism with vitiligo susceptibility in Gujarat population. Indian J. Dermatol. Venereol. Leprol. 84, 285\u2013291 (2018).","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"1569_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/ng0195-80","volume":"9","author":"JB Copeman","year":"1995","unstructured":"Copeman, J. B. et al. Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat. Genet. 9, 80\u201385 (1995).","journal-title":"Nat. Genet."},{"key":"1569_CR26","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1464-5491.2007.02096.x","volume":"24","author":"NC Schloot","year":"2007","unstructured":"Schloot, N. C. et al. Association of immune mediators at diagnosis of type 1 diabetes with later clinical remission. Diabetes Med. 24, 512\u2013520 (2007).","journal-title":"Diabetes Med."},{"key":"1569_CR27","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1210\/jcem.87.3.8351","volume":"87","author":"CA Meier","year":"2002","unstructured":"Meier, C. A. et al. IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin? J. Clin. Endocrinol. Metab. 87, 1184\u20131188 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1569_CR28","doi-asserted-by":"publisher","first-page":"e0155701","DOI":"10.1371\/journal.pone.0155701","volume":"11","author":"P Katra","year":"2016","unstructured":"Katra, P., Dereke, J., Nilsson, C. & Hillmnan, M. Plasma levels of the interleukin-1-receptor antagonist are lower in women with gestational diabetes mellitus and are particularly associated with postpartum development of type 2 diabetes. PLoS ONE 11, e0155701 (2016).","journal-title":"PLoS ONE"},{"key":"1569_CR29","doi-asserted-by":"publisher","first-page":"929","DOI":"10.2337\/db07-1697","volume":"57","author":"C Pfleger","year":"2008","unstructured":"Pfleger, C. et al. Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes. Diabetes 57, 929\u2013937 (2008).","journal-title":"Diabetes"},{"key":"1569_CR30","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.celrep.2018.01.063","volume":"22","author":"M B\u00f6ni-Schnetzler","year":"2018","unstructured":"B\u00f6ni-Schnetzler, M. et al. \u03b2 cell-specific deletion of the IL-1 receptor antagonist impairs \u03b2 cell proliferation and insulin secretion. Cell Rep. 22, 1774\u20131786 (2018).","journal-title":"Cell Rep."},{"key":"1569_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.tem.2015.08.001","volume":"26","author":"C Herder","year":"2015","unstructured":"Herder, C., Dalmas, E., B\u00f6ni-Schnetzler, M. & Donath, M. Y. The IL-1 pathway in type 2 diabetes and cardiovascular complications. Trends Endocrinol. Metabol. 26, 551\u2013563 (2015).","journal-title":"Trends Endocrinol. Metabol."},{"key":"1569_CR32","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1161\/CIRCULATIONAHA.107.740233","volume":"117","author":"A Abbate","year":"2008","unstructured":"Abbate, A. et al. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation 117, 2670\u20132683 (2008).","journal-title":"Circulation"},{"key":"1569_CR33","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1161\/01.ATV.20.11.2394","volume":"20","author":"R Dewberry","year":"2000","unstructured":"Dewberry, R., Holden, H., Crossman, D. & Francis, S. Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 20, 2394\u20132400 (2000).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1569_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.diabet.2007.10.006","volume":"34","author":"J Ybarra","year":"2008","unstructured":"Ybarra, J. et al. Gender-based dimorphic pattern for interleukin-1 receptor antagonist in type 2 diabetes mellitus. Diabetes Metab. 34, 75\u201381 (2008).","journal-title":"Diabetes Metab."},{"key":"1569_CR35","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.2337\/diab.43.10.1242","volume":"43","author":"T Mandrup-Poulsen","year":"1994","unstructured":"Mandrup-Poulsen, T. et al. Monokine antagonism is reduced in patients with IDDM. Diabetes 43, 1242\u20131247 (1994).","journal-title":"Diabetes"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01569-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01569-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01569-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T16:50:11Z","timestamp":1655225411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-021-01569-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,17]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["1569"],"URL":"https:\/\/doi.org\/10.1038\/s41390-021-01569-5","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,17]]},"assertion":[{"value":"10 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The current study was approved by the Medical Research Ethical Committee of the Faculty of Medicine, Benha University. All subjects were informed about the procedures and the aim of the study, and informed written consent was obtained from the parents or caregivers of enrolled children. The committee\u2019s reference number is not available.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}